Abstract:Hepatocytes express the specific C-type lectin, asialoglycoprotein (ASGP) receptor, on the surface to remove the ligand-bearing proteins from circulation. The specific expression and ligand specificity are thought to be the ideal characters for the target of drug or gene delivery. Various galactose-bearing molecules were synthesized for this purpose. However, the biological or functional interaction of these molecules with the ASGP receptor still remains to be elucidated. In this study. we evaluated the functional ability of synthetic galactose polymer ligand, poly-(N-p-vinylbenzyl-O-beta-D-galactopyranosyl-[1-4]-D-gluconamide) (PVLA), to interact with recombinant ASGP receptors using mouse ASGP receptor (mouse hepatic lectin; MHL) gene-transfected CHO cells. PVLA-coated beads bound to and were endocytosed by the whole (MHL-1/-2) ASGP receptor-expressing CHO cells like hepatocytes while PVMA (poly-(N-p-vinylbenzyl-O-beta-D-glucopyranosyl-[1-4]-D-gluconamide) did not. Interestingly, PVLA-coated beads were also endocytosed by either MHL-1 or MHL-2 alone expressing cells, which are known to be incapable of endocytosing natural ligands. In addition, the endocytosis of PVLA-coated beads by MHL-expressing CHO cells or primary hepatocytes was inhibited only by soluble PVLA but not by the same galactose molecular concentration of soluble asialofetuin. Furthermore, PVLA-coated beads were endocytosed by primary hepatocyte to a significantly higher degree than asialofetuin-coated beads in vitro. These results suggest that PVLA has higher affinity to the ASGP receptor than the natural ligands in blood. Consistently, it was demonstrated that intravenously injected FITC-labeled PVLA but not PVMA drastically accumulated in parenchymal cells of the liver in vivo. Taken together, PVLA exhibiting higher affinity with hepatocytes than natural ligands is thought to be an attractive and practical carrier-ligand for liver targeting.

Synthesis and Characterization of Galactosyl-Hsa (a Hepatic Targeting Drug Carrier)

Evaluation of Molecular Binding Modes on Site Ii of Human Serum Albumin

Preparation and evaluation of mixed-mode resins with tryptophan analogues as functional ligands for human serum albumin separation☆

Functional evaluation of poly-(N-ρ-vinylbenzyl-O-β-Dgalactopyranosyl-[1-4]-D-gluconamide)(PVLA) as a liver specific carrier

Synthesis and efficient hepatocyte targeting of galactosylated chitosan as a gene carrier in vitro and in vivo

Fabrication and Evaluation of Sdf-1 Loaded Galactosylated Chitosan Nanoparticles for Liver Targeting

Synthesis of Glutamic Acid-based Cluster Galactosides and Their Binding Affinities with Liver Cells

Development and Characterization of a Novel Fusion Protein of a Mutated Granulocyte Colony-Stimulating Factor and Human Serum Albumin in Pichia Pastoris.

Development of glycyrrhetinic acid ligand-functionalized liposomes for targeting hepatocellular carcinoma: synthesis, preparation, characterization, and evaluation

Effect of Hydrophile–Lipophile Balance of the Linker in Gal/GalNAc Ligands on High-Affinity Binding of Galactosylated Liposomes by the Asialoglycoprotein Receptor

[Synthesis of G3.5 Dendrimer-2-aminoethyl SS-D-galactopyranoside Conjugates and Its Specificity on Hepatocyte Targeting in Vitro].

Glycyrrhetinic acid-graft-hyaluronic acid conjugate as a carrier for synergistic targeted delivery of antitumor drugs.

[Liver Targeting of Cationic Liposomes Modified with Soybean-Derived Sterylglucoside in Vitro].

Construction of Efficacious Hepatoma-Targeted Nanomicelles Non-Covalently Functionalized with Galactose for Drug Delivery

Preparation of glycyrrhizic acid-modified BSA-nanoparticles and evaluation of their hepatic cellular distribution

Galactosylated low molecular weight chitosan as a carrier delivering oligonucleotides to Kupffer cells instead of hepatocytes in vivo.

Galactosylated low molecular weight chitosan as DNA carrier for hepatocyte-targeting.

Organ/Cell-Selective Intracellular Delivery of Biologics via N -Acetylated Galactosamine-Functionalized Polydisulfide Conjugates

Synthesis, Characterization, and in Vitro Evaluation of Two Synergistic Anticancer Drug-Containing Hepatoma-Targeting Micelles Formed from Amphiphilic Random Copolymer

Targeting delivery of oligonucleotide and plasmid DNA to hepatocyte via galactosylated chitosan vector.

Galactosylated chitosan oligosaccharide nanoparticles for hepatocellular carcinoma cell-targeted delivery of adenosine triphosphate